A review of therapeutic potential of Saussurea lappa-An endangered plant from Himalaya  by Zahara, Kulsoom et al.
S60
Document heading            doi: 10.1016/S1995-7645(14)60204-2                                              
A review of therapeutic potential of Saussurea lappa-An endangered 
plant from Himalaya 
Kulsoom Zahara, Shaista Tabassum, Sidra Sabir, Muhammad Arshad, Rahmatullah Qureshi, Muhammad Shoaib Amjad, 
Sunbal Khalil Chaudhari*
Department of Botany, PMAS Arid Agriculture University Rawalpindi, Pakistan
Asian Pac J Trop Med 2014; 7(Suppl 1): S60-S69
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
    *Corresponding author: Sunbal Khalil Chaudhari, Department of Botany, PMAS Arid 
Agriculture University Rawalpindi, Pakistan.
     E-mail: khalilsunbal@yahoo.com
1. Introduction
1.1. Geographical distribution
   Saussurea  lappa  (S.  lappa )  i s  indigenous  to 
Ind ia ,  P ak i s t an  and  C h ina ,  where  i t  g r ows  in 
the Himalaya region at 2 500-3 500 m alti tude[1]. 
1.2. Morphological description of S. lappa (Decne.) C.B. 
Clarke plant
   S. lappa C.B. Clarke, syn. Saussurea costus (Falc.) Lipsch 
belonging to family Asteraceae (Table 1), commonly known 
as Costus which is a tall, perennial herb that grows to a 
height of 1-2 m; stem is upright, stout and fibrous while root 
is a long stout of approximately 60 cm with a characteristic 
odour; leaves are lobate, stalked, membranous, irregularly 
toothed; upper leaves are small while basal leaves are large 
with long lobately winged stalks. Flowers are stalkless, dark 
purple to black in colour and are arranged in terminal and 
axillary heads (Figure 1). Pappas is approximately 1.7 cm 
long, fluffy, feathery giving an inquisitive appearance to the 
fruiting flower heads. Fruit of S. lappa is cupped, curved, 
compressed and hairy[2].
2. Active constituents of S. lappa
   Studies on the chemical ingredients of S. lappa could be 
traced back to 1950s. Until now, many compounds have been 
isolated. Its active constituents are mainly terpenes, but 
it also contains anthraquinones, alkaloids and favonoids. 
Plant has various terpenes that mainly have antitumor 
properties and anti-infammatory, such as costunolide, 
dihydrocostunolide, 12-methoxydihydrocostunolide, 
dihydrocostus lactone, dehydrocostus lactone[3], 
α-hydroxydehydrocostus lactone, β-hydroxydehydrocostus 
lactone, lappadilactone[4], mokko lactone, betulinic acid, 
betulinic acid methyl ester[5], cynaropicrin, reynosin, 
santamarine[6], saussureamines A-C[7], α-cyclocostunolide, 
alantolactone, isoalantolactone[8], isodihydrocostunolide, 
β-cyclocostunolide[9], 1β-hydroxy arbusculin A[5], 
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arbusculin B[10], saussureal and so on[11].  
Table 1











Genus Saussurea DC. 
Species S. lappa C.B. Clarke 
Figure 1. S. lappa floral part.
   S. lappa has three anthraquinone compounds, namely, 
aloeemodin-8-O-β-d-glucopyranoside, rhein-8-O-
β-d- glucopyranoside, and chrysophanol. Four favonoid 
glycosides have antibacterial function[12]. Shikokiols have 
antitumor activity[13], whereas chlorogenic acid prevents 
oxidization. 
3. Costus oil
   The oil extracted from the roots of S. lappa is known as 
costus oil, which is used in the preparation of hair oil and in 
high quality perfumes. Costus oil is pale yellow to brownish 
in color and is also said to be valuable in treating leprosy. 
   In a recent study, 39 components have been identified 
from the essential oil of S. lappa roots. The chief compounds 
were dehydrocostus lactone (46.75%), costunolide (9.26%), 8- 
cedren-13-ol (5.06%) and α-curcumene (4.33%). However, 
β-costol (13.55%) and δ-elemene (12.69%), α-selinene (5.02%), 
β-selinene (4.47%), α-costol (4.02%), 4-terpinol (3.38%), 
elemol (3.21%), α-ionone (3.13%), β-elemene (3.00%), (-)-γ- 
elemene (2.08%), p-cymene (1.96%) and 2-β-pinene (1.57%), 
(-)-α-selinene, (+)-selina-4, 11-diene, (-)-α-trans-
bergamotene, (-)-α-costol, (+)-γ-costol, (-)-elema-1,3,11 
(13)-trien-12-ol, (-)-α-costal, (+)-γ-costal, (-)-elema- 
1,3,11(13)-trien-12-al, (-)-(E)-trans-bergamota-2,12-dien-
14-al, (-)-ar-curcumene, (-)-caryophyllene oxide and 12-m
ethoxydihydrodehydrocostuslactone were also reported[14,15].
   However, in the other reported studies, the proportion 
of all these compounds greatly differs. Existing variations 
in the composition of S. lappa essential oil may be due to 
various factors related to ecotype, phenophases, chemotype 
and variations in environment conditions such as relative 
humidity, temperature, photoperiod and irradiance. 
Furthermore, the chemistry of secondary metabolites of 
plants may also be affected by genetic background[16].
4. Pharmacology
   S. lappa is a medicinally important plant. Various 
active compounds isolated from plant are reported to 
have medicinal properties e.g. the major components 
are sesquiterpene lactones such as costunolide and 
dehydrocostus lactone. S. lappa possesses various 
bioactivities such as antifungal[17], antidiabetic[18], 
anthelmintic[19], antitumor[20], antiulcer[21], antimicrobial[22], 
i m m u n o s t i m u l a n t [ 2 3 ] ,  a n t i i n f l a m m a t o r y [ 2 4 ]  a n d 
antihepatotoxic[25].
4.1. Anticancer/antitumor
   Costunolide (isolated from root of S. lappa) was studied 
for its effect and supposed pathways of action on the 
induction of apoptosis in HL-60 human leukemia cells. 
Using apoptosis analysis, evaluation of mitochondrial 
membrane potentials and measurement of reactive oxygen 
species (ROS), it was proved that costunolide was a potent 
apoptosis inducer, and by ROS generation aiding its activity, 
it induced mitochondrial permeability transition and 
released cytochrome C to the cytosol. In cells treated with 
costunolide, an antioxidant N-acetylcystein is responsible 
for blocking the mitochondrial alteration, ROS production, 
and consequent apoptotic cell death. Costunolide stimulates 
the ROS-mediated mitochondrial permeability transition and 
resultant cytochromes C release[26].
   The hexane extract of S. lappa was investigated for the 
chemo preventive potential in autonomous androgen prostate 
cancer and apoptosis induction in DU145 cells. Results of 
this study showed that dehydrocostus lactone isolated from 
the hexane extract of S. lappa induced apoptosis in cell lines 
of DU145 human autonomous androgen prostate cancer and 
inhibited the cell growth[27].
   Cynaropicrin isolated from S. lappa was assessed 
for its immunomodulatory effects on cytokine release, 
immunosuppressive effects, and nitric oxide production. 
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Cynaropicrin repressed Jurkat T, Eol-1 and U937 cell 
lines in a dose-dependent manner with IC50 values of 2.36, 
10.90 and 3.11 µmol/L respectively. Further, by means of 
DNA disintegration, cell cycle arrest and morphological 
analysis via U937 cells, its cytotoxic effect is studied. When 
cynaropicrin is treated in combination with ROS scavengers’ 
rottlerin, N-acetyl-L-cysteine or L-cysteine repressed the 
cynaropicrin mediated cytotoxicity. The results showed that 
cynaropicrin was more cytotoxic toward leukocyte derived 
cancer cells than fibroblasts[28].
   Costunolide is a sesquiterpene lactone isolated from S. 
lappa proved to have effect on carcinogenesis via reporter 
gene assay, persuaded by a tumor endorsing phorbol ester 
12-O-tetradecanoylphorbol-13-acetate at cellular level. 
The activity of nitric oxide synthase is amplified by tumor 
promoting phorbol ester 12-O-tetradecanoylphorbol-13-
acetate which consecutively repressed by costunolide with 
the IC50 value of 2 mmol/L[29]. 
   In another study, the effect of costunolide on telomerase 
inhibitory activity was investigated on MDA-MB-231, 
MCF-7 cells which confirmed the hindering activity[30]. 
Dehydrocostuslactone is another sesquiterpene lactone 
isolated from S. lappa and investigated for anticancer 
potential for non lung cancer cell lines, for example 
A549, NCI-H460 and NCI-H520 and its activity have been 
confirmed[31].
   Ethanolic extract of S. lappa showed that apoptosis 
followed in a dose and time dependent manner such as 80 
µg/mL and 48 h which gives confirmation for the treatment 
of gastric cancer by S. lappa[20].
   Hepatocellular carcinoma activity of dehydrocostuslactone 
was evaluated by in vitro assays, such as cell proliferation 
assay, immunoblot assay, assay for kinase activity, 
apoptosis and caspase activity assay. By using transmission 
electron microscopy, the in vivo analysis was done. The 
results proved its anticancer activity at the IC50 values 16.7 
and 18.8  µmol/L[32].
   Costunolide and dehydrocostus lactone had been 
isolated from different extracts of S. lappa. Costunolide 
and dehydrocostus lactone confirmed the cytolytic activity 
at ID50 of 3.6-10 µmol/L. At 13.6 µmol/L, costunolide 
completely inhibited the granule exocytosis in a dose-
dependent manner and even repressed the amplification 
in the tyrosine phosphorylation at different concentrations. 
Therefore, results disclosed that the costunolide performed 
in a mechanistic means by preventing the increase in the 
phosphorylation of tyrosine[33].
   Costunolide inhibits the vascular endothelial growth 
factor (VEGF)-induced chemotaxis of human umbilical vein 
endothelial cells in a dose-dependent manner. It was also 
found to selectively inhibit the endothelial cell proliferation 
induced by VEGF. The result of this study showed that 
by blocking the angiogenic factor signaling pathway, 
costunolide might inhibit angiogenesis. VEGF interacts 
with its cognate receptors, KDR/Flk-1 and Flt-1, and exerts 
its angiogenic effect. Costunolide is found to inhibit the 
autophosphorylation of KDR/Flk-1 without affecting that 
of Flt-1. These results suggest that costunolide may prove 
to be useful for the development of a new angiogenesis 
inhibitor[34]. C-17 polyene alcohol isolated from S. lappa 
exhibited moderate cytotoxicities against the human tumor 
cell lines A549, SK-MEL-2, SK-OV3, HCT 15 and XF 498[13].
4.2. Anti-inflammatory activity
   In Korean traditional prescriptions, S. lappa is frequently 
used for inflammatory diseases. Methanol extract of S. 
lappa was investigated. It was observed that at 0.1 mg/
mL concentration, it exhibited more than 50% of inhibition 
on the cytokine induced neutrophil chemotactic factor 
induction[35].
   Ethanolic extract of S. lappa was studied at a dose range 
of 50-200 mg/kg, for the acute and chronic inflammation 
induced in both mice and rats. The result of this study 
revealed that the extract showed considerable values for 
anti-inflammatory activity through carrageenan induced 
paw edema and peritonitis animal models[36]. Costunolide 
was investigated for anti-inflammatory activity and it 
was observed that costunolide hindered the protein and 
mRNA expression of interleukin-1b. By means of an 
electrophoretic mobility shift assay, it was confirmed that 
it also concealed the AP-1 transcription activity. So, all 
these activities proved the anti-inflammatory activity of 
costunolide[37].
   The potential of dehydrocostus lactone for the oxidative 
osteoblast  damage was investigated and showed 
considerable increase in the osteoblast growth and 
hydrogen peroxide. At 0.4-2 µg/mL of dose, the factors 
for example calcium deposition, collagen and alkaline 
phosphatase were improved. These results confirmed that 
dehydrocostus lactone compound had potential to be used 
against oxidative osteoblast damage[5].
   At the doses of 50, 100 and 200 mg/kg, the ethanolic 
extracts of S. lappa were assessed for their action on acute 
and chronic inflammation and at 50-200 mg/kg it showed 
considerable inhibition on carrageenan induced paw 
edema[36]. 
4.3. Hepatoprotective
   Constunolide and dehydrocostus lactone (isolated from S. 
lappa) had little effect on the viability of the cells. However, 
they showed inhibitory effect on human hepatoma Hep3B 
cells, and on the expression of the hepatitis B surface 
antigen (HBsAg). It is proved that these compounds inhibit 
the HBsAg production by Hep3B cells with IC50 of 1.0 and 2.0 
µmol/L, respectively. Northern blotting analysis proved that 
they suppress (HBsAg) gene expression mainly at the mRNA 
level. Moreover, in another human hepatoma cell line Hep 
A2 (derived from Hep G2 cells) by transfecting a tandemly 
repeat hepatitis B virus (HBV) DNA, the inhibitory effect of 
costunolide on replication of human liver cells was studied. 
Results showed that both costunolide and dehydrocostus 
lactone had the tendency to be developed as potent anti 
HBV drugs in the future[38].
4.4. Anti-ulcer and cholagogic
   The acetone extract of S. lappa and costunolide showed 
cholagogic effect and inhibitory effect on the formation of 
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gastric ulcer in mice[39]. The serum gastrin, variation in 
gastric acidity output, and plasma somatostatin concentration 
were observed during S. lappa decoction perfusion into 
the stomach of patients with chronic superficial gastritis 
and results revealed that the decoction could increase 
the endogenous motilin release and accelerate the gastric 
emptying[38]. S. lappa is one of the major ingredients of UL-
409, a formulation which possesses anti-ulcer activity and 
the activity is may be due to the intonation of defensive 
factors by improvement in gastric cytoprotection[40,41].
   Antiulcer activity of herbal formulation of S. lappa was 
tested in Wistar rats and male pigs. Orally 600 mg/kg drug 
was given. The drug showed significant effect in gastric 
ulceration induced by alcohol and aspirin, cold resistant 
induced ulcerations and duodenal ulcer models. It amplified 




   Costunolide and dehydrocostus lactone act as inhibitors 
of killing activity of cytotoxic T lymphocytes (CTL). Through 
preventing the increase in tyrosine phosphorylation, 
constunolide inhibited the killing activity of CTL in response 
to the crosslinking of T cell receptors as inhibitors of the 
killing function of CTL and the induction of intercellular 
adhesion molecule-1, dehydrocostus lactone from S. 
lappa and other guaianolides were examined for their 
structure activity relationship[33]. It was confirmed that the 
guaianolides moiety exhibited considerable inhibitory effects 
towards the induction of intercellular adhesion molecule-1 
and killing function of CTL[42]. 
4.6. Anticonvulsant activity
   Different extracts of S. lappa root were evaluated for the 
anticonvulsant activity by picrotoxin-induced convulsions, 
pentylenetetrazole and maximal electroshock tests 
performed in mice. It was proved that the petroleum extract 
of S. lappa roots showed potent anticonvulsant activity at a 
dose of 100 and 300 mg/kg[43].
4.7. Gastric function
   Decoction of S. lappa was given to patients affected with 
persistent superficial gastritis and checked for difference 
in factors such as serum gastrin, gastric acidity and plasma 
somatostatin. Decoction of S. lappa was also given to five 
healthy volunteers. It was observed that it sped up the 
gastric emptying time and discharge of endogenous motilin. 
However, no change is observed in plasma somatostatin, 
acidity output and serum gastrin levels[38].
4.8. Gastro-protective effect 
   Costunolide, saussureamines and dehydrocostus lactone 
isolated from the methanolic extract of S. lappa showed the 
gastro-protective effect in rats on acidified ethanol induced 
gastric mucosal lesions in a dose dependent manner (5 and 
10 mg/kg)[44].
4.9. Angiogenesis effect
   Endothelial cell proliferation (induced by vascular 
endothelia growth factor) is reported to be repressed by 
costunolide (isolated from S. lappa root). Studies proved 
that the chemotaxis induced by vascular endothelia 
growth factor of human umbilical vein endothelial cells 
was noticeably inhibited at IC50 of 3.4 µmol/L. Similarly by 
in vivo method the neo-vascularisation of mouse corneal 
stimulated by vascular endothelia growth factor is repoted 
to be inhibited at a dosage of 100 mg/kg/day. Inhibition of 
vascular endothelia growth factor on VEGFR KDR/Flk-1 was 
also proved through signaling pathway[34].
4.10. Hypoglycaemic
   When a comprehensive examination and clinical study on 
potent hypoglycemic plants of different regions from India 
was undertaken, S. lappa was found effective for obese 
diabetes[18].
4.11. Spasmolytic activity
   From studies, it was proved that S. lappa was significantly 
able to relax the contraction induced by carbachol (30 µmol/
L). S. lappa has been reported to have antiperoxidative 
effects possibly due to the presence of sesquiterpene 
lactones. It is known to suppress contractions in guniea-pig 
aorta. Sesquiterpenes are recognized to stimulate the sGC 
which stimulates extrusion of K+ ions and thereby reduces 
intrinsic Ca++ ions through activation of cGMP and PKG 
pathway, leading to relaxation of smooth muscles[32]. 
4.12. Anti-hepatotoxic activity
   Aqueous and methanolic extracts of S. lappa root were 
investigated for hepatotoxic activity in mice against 
lipopolysaccharide and D-galactosamine induced hepatitis. 
With different doses of S. lappa, pretreatment of mice led to 
rise in creatinine plasma levels in a dose dependent manner 
and alanine transaminase, aspartate aminotransferase 
level as well. Whereas post treatment led to the limited 
progression of the hepatic damage which was induced by 
lipopolysaccharide and D-galactosamine. By the studies 
it is proved that the root extract works against hepatotoxic 
activity[25].
4.13. Miscellaneous
4.13.1. Antidiarrheal activity 
   Methanol extract of S. lappa roots was investigated for 
antidiarrheal activity on Wistar rats and it was observed 
that administration of 100, 300 and 500 mg/kg body weight of 
dose showed 26.33, 32.28 and 66.77% inhibition of diarrhea, 
respectively. The standard drug (loperamide) showed 
significant reduction (68.02%) in diarrheal stool at the dose of 
5 mg/kg body weight. The result of this study showed that the 
dose of 500 mg/kg body weight showed nearly similar effect 
to that of standard drug loperamide in reducing diarrheal 
stool.
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   The methanol extract of S. lappa roots showed 32.28% 
inhibition of diarrhea at the dose of 300 mg/kg body weight. 
So, these findings clearly showed that the MeOH extract of 
S. lappa exhibited significant antidiarrheal activity[45].  
4.13.2. Hypolipidaemic
   Aqueous extract of S. lappa was orally administered to 
twenty-seven rabbits at a dose of 2 mg/kg body weight and 
showed significant hypolipidaemic effect. Reduction in 
serum cholesterol and serum triglycerides was also found to 
be significant[18].
4.13.3. Resistance to pathogenic microorganisms
   S. lappa or its combination with other herbs could be used 
clinically for the treatment of gastritis, gastric ulcer, skin 
diseases, refux esophagitis, hepatitis, diarrhea and some 
oral cavity diseases, which may be related to its capability 
to improve resistance to pathogenic microorganisms.
4.13.4. Resistance to Helicobacter pylori (H. pylori)
   H. pylori is an important pathogenic microorganism that 
causes many diseases, including functional diseases of the 
digestive tract (e.g., gastric cancer, gastritis and dyspepsia) 
as well as endocrine disorders and autoimmune[46]. S. lappa 
extract strongly inhibits all the strains tested with minimum 
inhibitory concentration value of approximately 40 mg/
mL[47-49].
   Various extracts of S. lappa was investigated for its 
antibacterial potential by using five strains of H. pylori and 
it showed highest minimum inhibitory concentration at the 
dosage of 40 µg/mL[50].
4.13.5. Resistance to Streptococcus mutans (S. mutans)
   S. mutans is the most important currently recognized 
cariogenic bacteria[51], traditionally used for treating 
oral cavity diseases such as tooth decay, bad breath, and 
periodontitis[27], which proposed that S. lappa may inhibit 
S. mutans. In another study, the effects of ethanolic extract 
were evaluated on the growth and acid production of S. 
mutans, as well as the synthesis and adherence of water-
insoluble glucans[52].
   Their results of this study showed that ethanolic extract 
(0.5 mg/mL to 4 mg/mL) inhibited the growth and acid 
production of S. mutans, reduced the adherence of S. 
mutans, and inhibited the synthesis of water insoluble 
glucans. Results proved that S. lappa astonishingly 
inhibited the cariogenic activity of S. mutans.
4.13.6. Resistance to other microorganisms
   The active ingredients of S. lappa inhibit the transfer and 
binding of R plasmids in Shigella fexneri[50]. Moreover, they 
inhibit the expression of the HBsAg as well as growth of 
other microorganisms and pathogens[38,53].
   Ethanolic extract of S. lappa  was assessed for 
antimicrobial potential using S. mutans. The study showed 
that the ethanolic extract caused significant (P<0.05) 
inhibition on the growth. In addition, it also reduced the 
adherence of S. mutans[52].
   The compounds KSR1-KSR4 were isolated by repeated 
chromatography (column and high performance liquid 
chromatography) of a flavonoid fraction obtained by 
processing of an ethanolic extract of powdered, dry S. 
lappa roots. Antifungal potential of S. lappa was assessed. 
By using microdilution technique, nine fungal strains 
i.e. Aspergillus niger, Aspergillus ochraceus, Aspergillus 
versicolor, Aspergillus flavus, Penicilium ochrochloron, 
Penicillium funiculosum, Trichoderma viride, Cladosporium 
cladosporioides and Alternaria. KSR4 possessed the highest 
antifungal potential, while KSR3 showed medium activity. 
Compounds KSR1 and KSR2, showed good activity[12].
4.13.7. Antiparasitic
   The activity of S. lappa against Trypanosoma cruzi, 
Clonorchis sinensis, and some nematodal infections 
were determined. Decoction of plant was given orally 
into Clonorchis sinensis infected rabbits and found to be 
effective up to some extent[54]. In the children infected with 
the respective worms, the efficacy of S. lappa was studied 
on the basis of percentage reductions in the faecal eggs/
gram counts. In the doses, tested S. lappa did not produce 
any adverse side effects[55,56]. The methanolic extract 
of S. lappa was investigated in axenic cultures with the 
epimastigote form of Trypanosoma cruzi, clone Bra C15 C2, 
at 27 °C in F-29 medium at a concentration of 100 mg/mL. 
It is proved that S. lappa extract exhibited antiparasitic 
activity.
4.13.8. Antiviral activity
   S. lappa root extract was investigated for its potential 
against HBV in human hepatoma Hep3B cells. Active 
compounds isolated from S. lappa such as costunolide 
and dehydrocostus lactone suppressed the expression of 
HBsAg with IC50 values of 1.0 and 2.0 mmol/L respectively. 
By northern blotting analysis, the suppression was 
also observed in HepA2 cell line, so it was confirmed 
that compounds present in S. lappa root extract had 
considerable activity against HBV[38].
5. Other uses
5.1. Perfumery
   The fragrant oil obtained from S. lappa is very valuable in 
perfumery. Its odour slightly resembles with the oil of orris. 
It is also blends with other oriental perfumes in a lasting 
manner[57].
5.2. Pesticidal
   The root, containing both the essential oil and the 
alkaloid, is a reliable insect repellant. In China, it is the 
basis of incense, made into sticks which are burned in home 
and in the temples for worship, and also serve through their 
smoke to keep gnats, mosquitoes, and other flying insects at 
a space. In India, the dried root yields brilliant fumigatory 
pastilles, which burn fairly well and as the Chinese joss-
sticks, it serves the same insectifugal function[58,59].
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6. Traditional uses
6.1. Ethnomedicinal uses
   S. lappa is one of the most commercially viable species 
among all the species of genus Saussurea. It is widely 
utilized in various indigenous system of medicine all around 
the world for treating variety of disorders such as tenesmus, 
diarrhea, vomiting, dyspepsia, inflammation[60,61]. It is 
also prescribed in irregular menstruation, tenesmus and 
abdominal pain[20,62].
   Medicinal properties of this plant are well documented 
in traditional Chinese medicine, ayurvedic medicine and 
the Tibetan system of medicine[63]. In the Handbook of 
Traditional Tibetan Drugs, out of the 175 formulations it 
was reported that S. lappa was one of the main ingredients 
in 71 formulations[64]. The roots of S. lappa have a strong 
and sweet aromatic odour with a bitter taste, and are used 
in controlling bronchial asthma and as an antiseptic. 
Preparations made from this species are also reported to 
cure various diseases and conditions including ophthalmic 
conditions, fever, cough, paralysis, asthma, deaf, tridosha, 
hysteria and headache[65,66].
   The plant is prehistoric and well known about 2 500 years 
ago. It is used in various ancient system of medicine such 
as Unani, Ayurveda and Siddha[67]. In Indian traditional 
systems of medicine, S. lappa is used either in combination 
with other drugs or as a single drug. The dried roots are 
somewhat bitter in taste and grey to yellow in colour. 
The essential oil obtained from roots is mostly used in 
medicine[68]. Its roots are mainly used in asthma, cough 
and also in treatment of chronic skin diseases, rheumatism 
and cholera[69,70]. Different preparations of roots are used 
by Ayurvedic physicians for the treatment of a range of 
ailments like cold, flatulence, pruritus, gout, epilepsy, 
headache, itching and leucoderma[71,72]. S. lappa is used as 
an important medicine for gout, erysipelas and promotes 
spermatogenesis. In Tibetan medicine, the roots are 
considered to have an acrid, sweet and bitter taste with a 
neutral potency. S. lappa is one of the important ingredients 
in several traditional Tibetan formulae that are used for 
chronic inflammation of the lungs, chest congestion e.g. 
hippophae and eliminator of lung inflammation[73]. The 
roots possess carminative, anthelmintic, analgesic and 
emmenagogic properties. It stimulates the brain and cures 
blood, liver and kidney disorders. Different preparations 
of S. lappa are prescribed in helminthic infestations, 
convulsions, gas, leprosy, cold, persistant hiccups, 
tuberculosis, quartan malaria, rheumatism, intestinal 
carcinogenesis and edema[26,74]. It is also used traditionally 
to cure skin diseases such as scabies, ringworm, bruises and 
cuts[75-77].
6.2. Ethnoveternary uses
   Locally, it is used against the heart diseases of cattle[78].
6.3. Other uses
   The powdered roots are sprinkled over crops as 
insecticides. The roots are used as insecticide to protect 
woollen fabrics, and as incense. The upper parts of its plants 
are used as fuel and fodder and dried leaves are smoked as 
tobacco[43]. It is also used to improve complexion, as a hair 
wash to kill lice and to turn grey hair to black[62,79]. Other 
traditional applications of S. lappa are shown in Table 2.
Table 2
Traditional methods of application of S. lappa.
Conditions Method of applications
Stomachache Root powder is taken with water. Decoction of root is taken. Root powder is roasted in mustard oil and the paste is applied on stomach
Headache Oil heated with root is applied
Cough and cold Root powder is taken with warm water
Throat infection Root is chewed
Backache and chest pain Root powder is taken with milk/decoction of root powder. Oil heated with root is massaged the affected area
Rheumatism and painful joints Root is roasted in ghee/butter, powdered and taken with milk. The above mentioned ghee/ butter is rubbed on the affected area 
and bandaged to keep warm.
Scanty urination Jaggery is mixed in the decoction of root powder which is then taken. Paste of root powder is applied on the stomach below the naval.
Skin rashes formed af ter 
insect bite
Root powder is roasted in ghee/butter and the ghee/butter is applied on the affected area
Exhaustion Pieces of root are burnt in hookah and the smoke inhaled
Lustre and growth of hair Hair is washed with decoction. Mustard oil is heated with root powder and the oil used as topical application on hair
Pustules Fine root powder is dusted on the wound. Mustard oil is heated with root powder and the oil is applied and bandaged
Fainting spells Root is rubbed in water and the water is used a nasal drops Fine powder of root is used for sneezing.
General weakness fatigue Root is boiled in milk and the milk is taken twice daily
Piles Root are taken along with the ‘Vacha’ (Acorus calamus) roots
Epilepsy The roots are taken with honey
Headache Paste of the root is applied
General weakness (as Rasayana) Root powder ingested with cow’s milk and cow’s ghee
Scalp scabies Essential oil of root is applied
Typhoid fever Decoction of root is taken
Persistant hiccups Root powder is ingested 
Leprosy Root powder is ingested 
Cold Decoction of root is taken
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7. Trade of S. lappa
   In the Himalaya along with the dominant high altitude 
genera for high number of endemic species, Saussurea is 
the second largest genera (35 spp.)[70]. As already mentioned 
S. lappa has great demand in pharmaceutical industry but 
during the last decade, the species for its threatened status 
has been more popularized globally. In past, due to high 
market demand and unchecked exploitation, the species 
was reported to be extinct in many pockets in the wild[75]. In 
order to conserve the species and to fulfil the growing trade 
requirements, commercial cultivation of S. lappa was taken 
up in various regions. It is now commercially grown on a 
extensive scale, from Kashmir to Garwhal in Uttar Pradesh 
(United Provinces) in the forested areas similar to where it 
grows naturally. 
   It has been introduced and cultivated in three 
southernmost provinces of China. Trade has been significant 
over a long period. For shipment to Arabia and the Red 
Sea ports, large amount of the root have customarily been 
exported from Kashmir to Bombay and Calcutta for use 
chiefly in perfumery and medicine. There has also been 
substantial movement of the product within China. Globally, 
China has exported a total of 1 024 tons of roots and derivates 
overall since 1983 to 2009 and India exported a total of 266 
tons during the same period. 
   Presently, France is one of the leading importers of the 
root. Medicinally, the drug is known as radix saussureae 
lappae and the product has been marketed under the names 
costus root and costus root oil, Putchuk or Patchak (the 
Bengali name), and now in India as Kuth. 
8. Challenges in conservation and sustainable use of S. 
lappa
   S. lappa is an important plant, used widely in traditional 
and herbal medicine, also utilized in modern medicine. 
Due to high demand, most of the natural populations of 
the species are either have been extirpated or are under 
destructive harvesting, therefore availability of this important 
plant is decreasing in the wild day by day. S. lappa is 
endemic to a geographically limited part of the Himalayas, 
and grows on moist slopes at altitudes of 2 600-4 000 m[80]. 
Apart from the restricted distribution, the harvesting of 
whole plant is one of the reasons for being threatened. This 
critically endangered species is enlisted in Appendix I of 
Convention on International Trade in Endangered Species 
of Wild Fauna and Flora (CITES). S. lappa is one of the 37 
Himalayan endangered medicinal plants that have been 
prioritized for in situ and ex situ conservation[81].
   Because of an endemic species to the Himalaya, 
the distribution of this species is fairly restricted to 
tremendously narrow geographical range[82], which makes 
it more vulnerable to extinction. Being an endangered 
species[56,83], it was enlisted in Appendix I of CITES. Trade 
of S. lappa is strictly prohibited under Foreign Trade 
Development Act-1992. It is first listed in Appendix II of 
CITES on 1.7.1975 as S. lappa and afterward up listed to 
Appendix I in 1985.
   Due to the various known uses, S. lappa is in high demand 
both internationally and at the local level. It is one of the 
most commercially used Appendix I CITES species for 
various complaints in numerous indigenous systems of 
medicine[2,84]. Saussurea costus has been in high demand 
in the pharmaceutical industry. During the last decade, 
the species has been even more popularized due to its 
threatened status globally. Due to uncontrolled exploitation 
of the species and high market demand, it was reported to 
be extinct in many pockets in the wild.
9. The way forward
   A multi-branched approach to maintain the resource base 
that includes in situ and ex situ conservation and selection of 
better-quality genotypes followed by their multiplication (by 
both biotechnological and conventional approaches) could 
well provide available solution to the problem.
9.1. Biotechnological interventions
   Since the value of medicinal plants depends on the amount 
of the active principle present in it, it would be enviable 
to carry out cultivation of superior clones (recognized as 
‘elite’). These elites can be acknowledged by chemo-
profiling and by the use of different molecular marker 
techniques. Thereafter, either or both conventional methods 
of propagation and tissue culture techniques can be used to 
multiply the plant for raising commercial plantations as well 
as for conservation.
   For the species which are difficult to regenerate by 
conventional methods and due to over exploitation by 
destructive harvesting, their populations have decreased. 
Micropropagation can be used as a feasible alternative. It is 
also useful in terms of the active principles present. There is 
lots of variability, and elites have been recognized based on 
their potential for yielding higher amount of active principle. 
   This technology can successfully be used to meet up 
the growing demand for clonally uniform elite plants of 
S. lappa. For large-scale production of plant cells from 
which secondary metabolites could be extracted besides 
micropropagation, cell suspension culture systems could be 
used.
   Cell culture systems have numerous major advantages 
as it is independent of space constraints, geographical and 
seasonal variations and offers a defined production system 
ensuring an uninterrupted supply of good quality products 
of high yield. It also allows for preset management of cell 
growth and regulation of metabolite processes which in turn 
will improve productivity and lessen labour costs.
9.2. Cultivation practices
   Cultivation has several advantages over collection from 
the wild. Due to environmental and genetic differences, wild 
harvested plants usually vary in quality and consistency 
which dangerously compromise economic returns. Similarly, 
local environmental conditions strongly control the efficacy 
of medicinal plants. A plant might fail to produce the active 
constituents of concern since temperature, day length, 
rainfall and soil characteristics are some of the factors that 
have serious effects on the potency of medicinal plants. 
Before arriving at suitable agro-techniques, these are some 
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parameters that need to be studied well. Biopesticides, 
better-quality planting material produced through 
micropropagation in combination with use of bio-fertilizers 
(mycorrhiza) and improved agro-techniques would enhance 
the yields even further and generate constantly higher 
financial returns to the growers. 
9.3. Post-harvest handling
   The quality of medicinal plants also depends on the 
manner of post-harvest handling. It is observed that during 
harvesting, handling and storage, the collectors of herbal 
material pay less consideration to quality of material. It 
has been reported that stored herbal drug samples very 
frequently harbour mycotoxin producing fungi. 
   Above the acceptable limit fixed by the World Health 
Organization for human consumption, such herbal drugs 
containing mycotoxins above would be rejected in the 
global market. Therefore, efforts should be made in order to 
encourage sustainable management of medicinal plants at 
the community level itself by highlighting the improvement 
of collection, cultivation and marketing practices.
10. Conclusion
   S. lappa is a renowned medicinal plant that is often 
prescribed in various indigenous systems of medicines 
chiefly those of India, China, Tibet and Korea. It is used 
for treatment of many ailments in allopathic and herbal 
system of medicine such as chronic skin diseases, 
rheumatism, cholera, cough and cold, persistant hiccups, 
stomachache, toothache, typhoid fever, rheumatism, 
quartan malaria, leprosy etc. Various active compounds 
isolated from S. lappa are reported to have medicinal 
properties. The major components are sesquiterpene 
lactones such as costunolide and dehydrocostus lactone. It 
has various biological activities such as anticancer, anti-
inflammatory, hepatoprotective, anti-ulcer and cholagogic, 
anticonvulsant, imunomodulator, gastroprotective, 
angiogenesis, hypoglycaemic, spasmolytic, anti-hepatotoxic, 
antidiarrheal, hypolipidaemic, antiparasitic, antimicrobial 
and antiviral activity. It is also considered as an important 
plant in terms of veterinary medicine and used against 
the heart diseases of cattle. The oil obtained from S. 
lappa is very valuable and used in perfumery. The root is 
considered as a reliable insect repellant as their smoke to 
keep gnats, mosquitoes, and other flying insects at a space. 
The preliminary experiments justify the reputation of the 
drug as a useful remedy against cancer[26-29]. The results 
of the different studies have empirically designated that 
S. lappa is effectual as an anti-inflammatory agent. Total 
methanol extract of S. lappa showed compelling inhibitory 
effect on the formation of TNF-alpha, a pro-inflammatory 
cytokine, in murine macrophage-like cell (RAW 264.7 cells). 
The activity guided purification resulted in the isolation of 
three sesquiterpene lactones, reynosin, cynaropicrin and 
santamarine, which in a dose dependent manner inhibited 
TNF-alpha production. Inflammation has been closely 
related to rheumatism. Therefore, the anti-inflammatory 
properties of S. lappa may be the reason for its ethnomedical 
use in rheumatism. Some of the chemical constituents of S. 
lappa have been found to have the potential to be developed 
as bioactive molecules. Costunolide and cynaropicrin 
have been identified as latent anticancer agents. Similarly, 
cynaropicrin has been identified as the principal inhibitor 
of TNF-alpha. Dehydrocostus lactone and costunolide 
have been reported to display strong suppressive effect on 
the expression of HBsAg in human hepatoma Hep3B cells 
and therefore have the potential to be developed as anti-
HBV drugs. Although the published confirmation to date 
supports the safety and perhaps the efficiency of S. lappa, 
the quality of the evidence is limited; active constituents, 
physiological pathways, pharmacokinetics, bioavailability, 
and importance to human health are not known with 
sufficient detail or assurance. Since S. lappa has various 
medicinal applications, that’s why more in vitro, clinical 
and pathological studies are required to investigate the 
unexploited potential of this plant.
   As already mentioned, S. lappa has great demand in 
pharmaceutical industry. So due to high demand, most 
of the natural populations of the species are either have 
been extirpated or are under destructive harvesting. It is 
endemic to a geographically limited part of the Himalayas.
This critically endangered species is enlisted in Appendix 
I of CITES. However, a multi-branched approach including 
in situ and ex situ conservation and selection of better-
quality genotypes followed by their multiplication could well 
provide available solution to the problem.
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